Ischemic Stroke Admissions, Life-Saving Thrombectomy Procedures Decrease During Start of COVID-19 Pandemic

Researchers call for a response to current and future pandemics to reduce unintended harm upon other patients needing early diagnosis and intervention.

1:50 PM

Author | Haley Otman

Drawing of hospital bed on notebook paper
Image by Stephanie King.

A new research letter reveals fewer people have been admitted to stroke centers in Michigan and northwest Ohio since the onslaught of the COVID-19 pandemic, and even fewer patients have received the life-saving procedure, mechanical thrombectomy, for the most severe form of ischemic stroke.

The authors call COVID-19's negative influence on other critical illnesses including stroke the bystander effect.

"Stroke is a disease where minutes count and thus delay in presentation to the hospital as well as strains in personnel and facility resources may have led to the bystander effect," says lead author Aditya Pandey, M.D., associate professor of neurosurgery at Michigan Medicine.

In the letter, Pandey and colleagues from Michigan Medicine and across the state's Michigan Stroke Treatment Improvement Collaborative reported a significant reduction in ischemic stroke admissions in March when compared to both February of this year (17.8%) and to March of 2019. Similarly, procedures for the most severe ischemic strokes, mechanical thrombectomy, significantly declined this March compared to February 2020 and March 2019.

"A combination of patient fears, stringent patient transfer criteria, and health system strains may have contributed to lower ischemic stroke admissions as well as the near disappearance of thrombectomy procedures," the authors write.

The differences were most pointed in number of ischemic stroke admissions and thrombectomy procedures, authors say, while there was less of a change compared to past months for hemorrhagic stroke.

Paper cited: "Letter: COVID-19 Pandemic—The Bystander Effect on Stroke Care in Michigan," Neurosurgery. DOI: 10.1093/neuros/nyaa252


More Articles About: Lab Notes Covid-19 stroke infectious disease
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Enlargement of microscopic HIV virus cells
Health Lab
Researchers open new leads in anti-HIV drug development, using compound found in nature
Researchers open new leads in anti-HIV drug development, using a compound found in nature
Pink, blue, purple illustration of COVID-19 virus
Health Lab
Four years later, what do we know about COVID-19?
Today, thanks to researchers, medical and public health experts, pharmaceutical companies, engineers and others, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before.
Illustration of scientists and doctors playing basketball in white coats and scrubs
News Release
Four U-M teams selected for virtual tournament of science
U-M researchers' work made the bracket in the 2024 STAT Madness tournament of science, and need public support to advance
Health care provider loads syringe with measles vaccine
Health Lab
Measles: 10 things to know about immunization and prevention
Measles: 10 things to know about immunization and prevention
Graphic showing pills, a heart and brain with data on aspirin use
Health Lab
Aspirin can prevent a second heart attack or stroke, but many don’t use it
Washington University School of Medicine and Michigan Medicine researchers found that fewer than half of people who have experienced a heart attack or stroke use aspirin to prevent a second one.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
The Intersection of Artificial Intelligence & Alzheimer’s Disease and Related Dementias
In this episode, Matt and Donovan talk with Dr. Jason H. Moore, Director of the Center for Artificial Intelligence Research and Education (CAIRE) and Chair of the Department of Computational Biomedicine at Cedars-Sinai Medical Center. Jason discusses the coming impact of artificial intelligence on a spectrum of Alzheimer’s disease and related dementia (ADRD) issues. We discuss how tools such as AI-powered chatbots may improve quality of life for people living with dementia (and their caregivers) and how AI may contribute in the future to diagnosis and treatment.